HER2-Overexpressing Breast Cancers Amplify FGFR Signaling upon Acquisition of Resistance to Dual Therapeutic Blockade of HER2

Erstveröffentlichung
2017
Authors
Hanker, Ariella B.
Garrett, Joan T.
Estrada, Monica Valeria
Moore, Preston D.
Ericsson, Paula Gonzalez
et al.
Wissenschaftlicher Artikel


Published in
Clinical Cancer Research ; 23 (2017), 15. - S. 4323-4334. - ISSN 1078-0432. - eISSN 1557-3265
Link to publication
https://dx.doi.org/10.1158/1078-0432.CCR-16-2287
Institutions
UKU. Klinik für Frauenheilkunde und Geburtshilfe
Subject headings
[Free subject headings]: kinase inhibitor lapatinib | ccnd1 amplification | acquired-resistance | erbb receptors | solid tumors | open-label | growth | trastuzumab | oncogene | cells
[DDC subject group]: DDC 610 / Medicine & health
Metadata
Show full item record